Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53–MDM2 interaction-Reference-Cited by-同舟云学术

Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53–MDM2 interaction

Published:2015-01 Issue: Volume:66 Page:138-147
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Soares Joana,Pereira Nuno A.L.,Monteiro Ângelo,Leão Mariana,Bessa Cláudia,dos Santos Daniel J.V.A.,Raimundo Liliana,Queiroz Glória,Bisio Alessandra,Inga Alberto,Pereira Clara,Santos Maria M.M.,Saraiva Lucília

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference19 articles.

1. Stereoselective synthesis of the pyrroloisoquinoline ring system;Allin;J. Chem. Soc. Perkin Trans.,2001

2. The Protein Data Bank;Berman;Nucleic Acids Res.,2000

3. Isoindolinone-based inhibitors of the MDM2–p53 protein–protein interaction;Hardcastle;Bioorg. Med. Chem. Lett.,2005

4. Isoindolinone inhibitors of the murine double minute 2 (MDM2)–p53 protein–protein interaction: structure–activity studies leading to improved potency;Hardcastle;J. Med. Chem.,2011

5. P53–Mdm2 inhibitors: patent review (2009–2010);Kamal;Expert Opin. Ther. Pat.,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chiral Ionic Covalent Organic Framework as an Enantioselective Fluorescent Sensor for Phenylalaninol Determination;Analytical Chemistry;2023-07-16

2. Design, synthesis, and molecular modeling of coumarin derivatives as MDM2 inhibitors targeting breast cancer;Chemical Biology & Drug Design;2022-02-22

3. Bicyclic 5-5 Systems With One Bridgehead (Ring Junction) Nitrogen Atom: One Extra Heteroatom 1:0;Comprehensive Heterocyclic Chemistry IV;2022

4. Preliminary Biological Activity Screening of Plectranthus spp. Extracts for the Search of Anticancer Lead Molecules;Pharmaceuticals;2021-04-23

5. Development of lipid nanoparticles containing the xanthone LEM2 for topical treatment of melanoma;Journal of Drug Delivery Science and Technology;2021-02